• EN - English
  • FR - français
  • IT - italiano
Parliamentary question - E-000869/2022Parliamentary question
E-000869/2022

France adding cholecalciferol (vitamin D) to the list of substances of very high concern as an endocrine disruptor

Question for written answer  E-000869/2022
to the Commission
Rule 138
Michèle Rivasi (Verts/ALE), Piernicola Pedicini (Verts/ALE), Tilly Metz (Verts/ALE)

On 25 October 2021, France notified the Commission and Member States of a draft decree in which the main form of vitamin D, cholecalciferol, is included in the list substances of very high concern (SVHC) as an endocrine disruptor[1]. The European Food Safety Authority (EFSA) states that Vitamin D ‘plays an important role in the body’[2]. In a November 2021 report it noted that the vitamin D status in European populations was ‘inadequate in a large proportion of children and adults’[3].

In 2018, in its assessment of a biocidal product containing cholecalciferol, the European Chemicals Agency (ECHA) appears to have concluded that the substance can disrupt the endocrine system at high doses but only has beneficial effects at the authorised doses for food and supplements[4].

How will the Commission respond to France’s draft decree to make it clear that cholecalciferol cannot be considered an endocrine disruptor at the authorised doses for food and supplements?

Last updated: 15 March 2022
Legal notice - Privacy policy